Infection Control News

If given to patients with early and symptomatic COVID-19, treatment with remdesivir can accelerate the rate of viral clearance in oropharyngeal swabs over 1 week, researchers found.

The CDC launched a new antisepsis program for U.S. hospitals that was modeled after the agency’s “Core Elements” framework for developing antibiotic stewardship programs.

A study of more than 30,000 hospitalized children with SARS-CoV-2 infection found that ICU admissions for COVID-19 decreased over the course of the pandemic but ventilatory and oxygen support for the youngest children did not.

Novavax on Tuesday said its updated COVID-19 vaccine candidate induced neutralizing antibodies against emerging SARS-CoV-2 subvariants in small animal and non-human primate studies.

Only a handful of commonly used disinfectants — primarily chlorine-based disinfectants — were consistently effective against the four major clades of Candida auris, researchers reported.

Health care workers who picked their nose were three times as likely to acquire SARS-CoV-2 as those who did not, according to recent study results.

Moderna this week said preliminary clinical trial data confirmed that its updated COVID-19 vaccine provides a “significant boost” in neutralizing antibodies against emerging SARS-CoV-2 viruses and is expected to effectively target them.

In the wake of the FDA approval of the first over-the-counter birth control pill, two experts argued that the time has come to make another prevention medication available without a prescription.

The AAP published guidance on the use of nirsevimab, recommending it for all infants aged younger than 8 months to prevent severe disease from respiratory syncytial virus.

The FDA extended the review period for Valneva’s chikungunya vaccine candidate by 3 months while the design of a phase 4 study is finalized.